Jan 17, 2009
ST LOUIS, January 17, 2009 – Veran Medical Technologies exhibited its SPiN IR™ System at the Inaugural Symposium on Clinical Interventional Oncology. The Symposium on Clinical Interventional Oncology met the needs of interventionalists who wish to acquire knowledge and skills in this emerging field. Veran was highlighted for its cutting edge technology by the CIO community in an article the January 18th issue of ISET Today. The Symposium was presented in association with the 20-year old International Symposium of Endovascular Therapy (ISET). “We are very excited about the growing interest about navigation in the interventionalist practice,” said Jerome R. Edwards, President and CEO of Veran Medical Technologies. “The potential benefits which our SPiN IR™ System bring related to faster, safer, and more efficient procedures is being demonstrated with the sites that are using our system.”
Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s main focus is assisting physicians in the early diagnosis and treatment of lung cancer. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined.
Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System™. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States. Veran provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked® instruments and Veran’s exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists.
Another challenge lung specialists face is that approximately 40% of lung nodules lie outside of an airway, making them very difficult to reach endobronchially, and traditionally requiring an additional procedure. Veran’s SPiN Thoracic Navigation System™ is the first and only FDA cleared technology that enables Pulmonologists or Thoracic Surgeons to safely and accurately access lung nodules outside of an airway using SPiN Perc™, a navigated transthoracic needle. With SPiN Perc™, Veran combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. The early diagnosis and treatment of lung cancer has been proven to save lives.
Media Inquiries: Please Contact TJ Meyer at email@example.com